STAT Plus: FDA rejects Intarcia’s diabetes implant for a second time
For the second time, the Food and Drug Administration rejected an Intarcia Therapeutics implant aimed…
Category: Biotech
STAT Plus: Drug companies, Canadians, pharmacists and more blast Trump’s drug importation plan
WASHINGTON — The Trump administration is being flooded with opposition to its plan for allowing…
U.S. communities are braced for coronavirus outbreaks. Seattle is already in the thick of it
SEATTLE — As much of the United States prepares to see large clusters of Covid-19,…
STAT Plus: Global companies expand the reach of their cancer drugs in China
While much of the world is understandably focused on the new coronavirus’s emergence in China,…
FDA halts inspections of foreign plants through April due to coronavirus
The ongoing spread of the novel coronavirus has prompted the Food and Drug Administration to…
Washington, the world’s handshake capital, adjusts to life in the coronavirus era
WASHINGTON — When Vice President Mike Pence reached for a handshake on Thursday, Jan Malcolm,…
PhRMA closes its D.C. headquarters after visitor tests positive for coronavirus
WASHINGTON — The Pharmaceutical Research and Manufacturers of America, the Washington lobbying arm for the…
Opinion: What does the coronavirus mean for the U.S. health care system? Some simple math offers alarming answers
Much of the current discourse on — and dismissal of — the Covid-19 outbreak focuses…
STAT Plus: Pharmalittle: Gates Foundation and others plan $125 million coronavirus effort; India considers lifting export restrictions
Rise and shine, everyone, another busy day is clearly on the way. The world seems…
STAT Plus: Clinical research company sued over stolen trade secrets after employee filmed dogs used in experiments
Nearly two years ago, Charles River Laboratories (CRL) paid $800 million for a company called…
Watch: In prescient move, Bill Gates urged Trump to invest in pandemic preparedness two years ago
In words that now seem prescient, Bill Gates said in an interview with STAT two…
Opinion: If Covid-19 gets bad, triage will be needed. Are we ready for that?
The emergence of a new infectious disease that rapidly spreads around the world, like Covid-19,…
Opinion: I thought I understood the Sacklers’ opioid empire. Startling documents from a whistleblower and declassified government files proved me wrong
What could possibly be new about the Sackler family, the billionaire owners of Purdue Pharma?…
The coronavirus outbreak has left medical supplies in short supply. Is the nation’s emergency stockpile ready to help?
WASHINGTON — The U.S. government has a secretive, $7 billion stash of emergency medical equipment…
$125M effort to find coronavirus drugs started by Gates Foundation, Wellcome, and Mastercard
The Bill & Melinda Gates Foundation, along with the charitable group Wellcome and Mastercard, announced…
STAT Plus: Debates over biosimilar uptake notwithstanding, sales growth should accelerate by 2024
Despite various issues that have slowed biosimilar uptake by the U.S. health care system, usage…
STAT Plus: ‘Unleash that data’: Medicare chief promotes freer exchange of medical records, highlights efforts to protect privacy
After a year of intense lobbying, the Trump administration on Monday finalized federal rules to…
Coronavirus spread could last into next year, but impact could be blunted, CDC official says
A top federal health official said Monday that the evolving coronavirus outbreak could persist in…
STAT Plus: A recently approved Gilead HIV prevention pill is not cost-effective and should be cut in half, study says
The price of a Gilead Sciences (GILD) pill approved in the U.S. last fall to…
People ‘shed’ high levels of coronavirus, study finds, but most are likely not infectious after recovery begins
People who contract the novel coronavirus emit high amounts of virus very early on in…
Pace of medical conference shutdowns is accelerating as the coronavirus outbreak spreads
Tanat Chinbunchorn, a physician and HIV prevention researcher, was mid-flight between Bangkok, Thailand, and Boston…
New Trump rules aim to fuel sharing of patient health records by smartphone
President Trump’s top health care aides on Monday said they will finalize federal rules requiring…
STAT Plus: Pharmalittle: Will some coronavirus vaccines make infections worse? Not all biopharma execs have prepared
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Opinion: Doctors working while sick is bad enough in ordinary times. During the Covid-19 outbreak it could be catastrophic
Earlier this winter, before the coronavirus outbreak, I spoke by phone with a colleague who…
Opinion: Can you sue an algorithm for malpractice? It depends
The rapid entry of artificial intelligence is stretching the boundaries of medicine. It will also…
Heart Association admits teaming with Bayer on drug-store aspirin displays was a ‘misstep’
The large red-and-white bins at Walmart pharmacies across the country read, in bold all-caps type:…
How touching your face can spread viruses — and why you’re so bad at avoiding it
With the outbreak of Covid-19, health care professionals are urging people to regularly refrain from…
.jpg)
To develop a coronavirus vaccine, synthetic biologists try to outdo nature
Even as companies rush to develop and test vaccines against the new coronavirus, the Bill…
STAT Madness voting ends tonight. Cast your vote for the best innovations in biomedicine
Welcome to the fourth annual STAT Madness, a bracket-style tournament to find the best innovations…
STAT’s guide to health care conferences disrupted by the coronavirus crisis
As the novel coronavirus races around the globe, a growing number of conference organizers are…
At Harvard forum, three who know warn of ‘most daunting virus’ in half a century
CAMBRIDGE, Mass. — For a veteran epidemiologist, an authority on homeland security, and a global…
Top Biogen execs were present at meeting where attendees had Covid-19
Biogen’s CEO, chief financial officer, and head of research and development were among those at…
STAT Plus: Pharmalittle: Former Gates Foundation chief is ‘very worried’ about coronavirus; FDA does little to clarify CBD rules
And so, another working week will soon draw to a close. Not a moment too…
STAT Plus: Private equity firms are increasingly buying up doctors’ offices. What does that mean for doctors — or for patients?
WASHINGTON — Can private equity firms provide quality health care? It’s the question that patients,…
Susan Desmond-Hellman: The coronavirus is alarming. Here’s why you should not panic
Susan Desmond-Hellmann has a unique set of experiences. Until February, she was the CEO of…
Opinion: Five years on, biosimilars need support from all health care players
Today marks a milestone for the U.S. biosimilar market: the FDA approved our first biosimilar,…
We’re learning a lot about the coronavirus. It will help us assess risk
It has been two months since China announced a previously unknown virus had been identified…
Listen: Pharma’s response to coronavirus, Google’s appetite for health data, and biotech’s rise in China
Does “The Art of the Deal” cover vaccines? Is patient privacy a relic of the…
STAT Plus: Congress asked the FDA to explain its rules on CBD — but its new report offers little clarity
WASHINGTON — A new report on cannabidiol, or CBD, from the Food and Drug Administration,…
Progressives push Trump administration to ensure a future coronavirus vaccine is affordable
WASHINGTON — Progressive Democrats are pushing to constrain how much drug makers can charge for…
STAT Plus: Gene and cell therapies continue growth in patients, financing, and costs
The number of people treated with approved gene therapies and gene-modified cell therapies like CAR-T…
Covid-19 epidemic forces cancellation of HIMSS health tech conference
The health care technology trade group HIMSS has canceled its annual conference for the first…
STAT Plus: The Engine at MIT is revving up the potential of ‘tough tech’
If you happen to bump into Bill Gates or Tim Cook in Central Square in…
Opinion: Super Tuesday results suggest that Americans ‘aren’t looking for big structural changes’ in health care
Voters on Tuesday sent several messages, including a key one about health care. Big ideas…
Opinion: Coronavirus spending: an expense — or an investment?
In the context of a looming global pandemic, what does it mean to invest in…
STAT Plus: Pharmalittle: Coronavirus vaccine testing starts in Seattle area; New Mexico law caps monthly insulin co-pay at $25
Hello, everyone, and how are you today? We are doing just fine, thank you, courtesy…
How blood plasma from recovered patients could help treat the new coronavirus
When it comes to creating treatments for Covid-19, the disease caused by the novel coronavirus,…
Opinion: A coronavirus vaccine should be for everyone, not just those who can afford it
As the coronavirus that causes COVID-19 spreads in more than 60 countries, the race to…
Opinion: It will take a village to solve the epidemic of maternal deaths in the U.S.
The phrase “maternal deaths” tends to conjure up images of awful complications of delivery: uncontrollable…
From ferrets to mice and marmosets, labs scramble to find right animals for coronavirus studies
One lab is digging into its freezer to thaw out the archived sperm of SARS-susceptible…